- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04810715
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis Ultrasonographic Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Posterior tibial tendon dysfunction is the most common cause of acquired pes planus deformity in healthy adults. The posterior tibial tendon stabilizes the hindfoot against valgus and eversion forces and acts as a support along the medial longitudinal arch. If the posterior tibial tendon loses its functionality, the other ligaments of the foot and the joint capsule gradually weaken as the height of the medial longitudinal arch decreases or disappears, and it develops with pes planus. The presence of pes planus and spondyloarthropathy are also risk factors for the development of posterior tibial tendon dysfunction.
100 participants aged between 20-70 years with ankylosing spondylitis were planned to be included in this investigation. Posterior tibial tendon dysfunction frequency of patients with ankylosing spondylitis will be evaluated by both clinical examination and musculoskeletal ultrasonography device. The posterior tibial tendon will be evaluated by ultrasonography in terms of tendon diameter and fluid presence in 2 different locations in the retromalleolar area.
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Ankylosing Spondylitis Quality of Life (ASQoL) Scale, Functional reach test, Timed up and go test, Berg Balance Scale, Dynamic and static balance with the Sportkat device will be used as evaluation parameters. It was planned that the evaluations were made once.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Afyonkarahisar, Turkey, 0300
- Afyonkarahisar
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Participitans who apply to the rheumatology outpatient clinic between the ages of 20-70 and who have been diagnosed with ankylosing spondylitis according to the Modified Newyork criteria will be included in this study.
- Ankylosing Spondilitis
Exclusion Criteria:
- Malignity
- Previous ankle surgery history
- Muscle disease
- Neuropsychiatric illnesses
- İmbalance
- Visual problems
- Deafness
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patient Group
Anklyosing Spondilitis
|
Observational study, not applicable
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
Time Frame: Will be done only once on the first day after inclusion
|
BASDAI includes six questions evaluating five important findings of the disease (Fatigue, hip and spine pain, swelling and pain in peripheral joints, enthesitis, duration and severity of morning stiffness). The pain levels of the patients will be evaluated with a Visual Analog scale (0: I have no pain, 10: I have very severe pain). Higher scores mean active disease. |
Will be done only once on the first day after inclusion
|
|
Bath Ankylosing Spondylitis Functional Index (BASFI)
Time Frame: Will be done only once on the first day after inclusion
|
BASFI; consists of eight questions that evaluate the function of patients with AS and two questions that evaluate their daily life.
Higher scores indicate greater limitations.
|
Will be done only once on the first day after inclusion
|
|
Ankylosing Spondylitis Quality of Life Scale (ASQOL)
Time Frame: Will be done only once on the first day after inclusion
|
Ankylosing Spondylitis Quality of Life (ASQoL) scale is a disease-specific assessment parameter designed to measure health-related quality of life.
It includes yes or no questions with a total score ranging from 0 to 18.
The lower scores represent better quality of life.
|
Will be done only once on the first day after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional reach test
Time Frame: Will be done only once on the first day after inclusion
|
Functional reach test: It is the maximum distance that the participants can reach forward in the horizontal plane while maintaining her/his stability on the support surface in the standing position.
|
Will be done only once on the first day after inclusion
|
|
Timed up and go test (TUG)
Time Frame: Will be done only once on the first day after inclusion
|
The TUG test is a simple evaluative test used to measure functional mobility.
It uses the time that participants take to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees.
During the test, the participant is expected to wear their regular footwear and use any mobility aids that they would normally require.11-20
seconds are within normal limits for frail elderly and disabled patients, and greater than 20 seconds means the worse scores.
|
Will be done only once on the first day after inclusion
|
|
Berg Balance Scale
Time Frame: Will be done only once on the first day after inclusion
|
The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks.
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.
The total score is 56.
A score of < 45 indicates participants may be at greater risk of falling.
|
Will be done only once on the first day after inclusion
|
|
Foot and Ankle Outcome Score (FAOS)
Time Frame: Will be done only once on the first day after inclusion
|
The FAOS is a 42-item questionnaire assessing patient-relevant outcomes in five separate subscales (Pain, other Symptoms, Activities of daily living, Sport and recreation function, foot and ankle-related Quality of life).
Scores range from 0 to 100 with a score of 0 indicating the worst possible foot/ankle symptoms and 100 indicating no foot/ankle symptoms.
Lower scores mean the worse scores.
|
Will be done only once on the first day after inclusion
|
|
Ultrasonographic evaluation of the posterior tibial tendon
Time Frame: Will be done only once on the first day after inclusion
|
Posterior tibial tendon evaluation will be evaluated in 2 different locations in the retromalleolar area.Tendon diameter, continuity and fluid presence will be evaluated ultrasonographically. Power Doppler signal levels will be graded on a 4-point semi-quantitative scale (none-grade 0 / minor-grade 1 / middle-grade 2 / severe-grade 3).
|
Will be done only once on the first day after inclusion
|
|
Static and Dynamic Balance measurment with SportKAT Device.
Time Frame: Will be done only once on the first day after inclusion
|
The SportKAT device used for determining postural oscillation consists of a balance platform and sensors that detect oscillations.There is a screen in front of the participant standing on the platform to provide feedback.
During the static balance test, it is asked to keep the 'X' mark seen on the screen constant in the center.
During the dynamic balance test, it is asked to to follow the moving cursor.
The score range varies between 0 and 6000.
The lower the score, the better the balance.
|
Will be done only once on the first day after inclusion
|
Collaborators and Investigators
Investigators
- Principal Investigator: Nuran EYVAZ, MD, Afyonkarahisar Health Sciences University
Publications and helpful links
General Publications
- Arnoldner MA, Gruber M, Syre S, Kristen KH, Trnka HJ, Kainberger F, Bodner G. Imaging of posterior tibial tendon dysfunction--Comparison of high-resolution ultrasound and 3T MRI. Eur J Radiol. 2015 Sep;84(9):1777-81. doi: 10.1016/j.ejrad.2015.05.021. Epub 2015 May 21.
- Guelfi M, Pantalone A, Mirapeix RM, Vanni D, Usuelli FG, Guelfi M, Salini V. Anatomy, pathophysiology and classification of posterior tibial tendon dysfunction. Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):13-19.
- Hasler P, Hintermann B, Meier M. Posterior tibial tendon dysfunction and MR imaging in rheumatoid arthritis. Rheumatol Int. 2002 May;22(1):38-40. doi: 10.1007/s00296-002-0183-1.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Congenital Abnormalities
- Foot Diseases
- Joint Diseases
- Musculoskeletal Diseases
- Arthritis
- Spinal Diseases
- Bone Diseases
- Spondylarthropathies
- Musculoskeletal Abnormalities
- Limb Deformities, Congenital
- Foot Deformities
- Bone Diseases, Infectious
- Ankylosis
- Foot Deformities, Acquired
- Foot Deformities, Congenital
- Lower Extremity Deformities, Congenital
- Talipes
- Spondylitis
- Spondylarthritis
- Spondylitis, Ankylosing
- Flatfoot
- Posterior Tibial Tendon Dysfunction
Other Study ID Numbers
- NEAS2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spondylitis, Ankylosing
-
Eighth Affiliated Hospital, Sun Yat-sen UniversityGuangzhou Cellgenes Biotechnology Co.,LtdNot yet recruitingAnkylosing SpondylitisChina
-
Saglik Bilimleri UniversitesiRecruitingAnkylosing SpondylitisTurkey (Türkiye)
-
Henan Provincial People's HospitalThe Second Affiliated Hospital of Henan University of Traditional Chinese...Withdrawn
-
SPH-BIOCAD (HK) LimitedCompleted
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingActive Ankylosing SpondylitisChina
-
AbbVieBoehringer IngelheimCompletedAnkylosing Spondylitis (AS)
-
Sun Yat-sen UniversityUnknownEarly Ankylosing Spondylitis
-
Tongji HospitalNovartis; Johns Hopkins Bloomberg School of Public Health; Wuhan Central Hospital and other collaboratorsRecruitingAnkylosing Spondylitis (AS)China
-
China-Japan Friendship HospitalThe Second Affiliated Hospital of Henan University of Traditional Chinese...Recruiting
Clinical Trials on Patients with Ankylosing Spondylitis
-
Bozyaka Training and Research HospitalSuspended
-
Istanbul Medeniyet UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedOvarian Diseases | Ankylosing Spondylitis | Anti-Mullerian Hormone DeficiencyTurkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Thailand, China, Philippines
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Bezmialem Vakif UniversityCompleted
-
Marmara UniversityCompletedAxial Spondyloarthritis | Central SensitisationTurkey
-
Showa UniversityUniversity of BolognaUnknownNausea and Vomiting Complain in Early PregnancyIndonesia
-
AbbVieCompletedRheumatoid ArthritisUnited States, Bulgaria, Chile, Czechia, Hungary, Israel, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Slovakia, South Africa, Spain, Turkey, Ukraine